Caricamento...
Does anti-reflux surgery disrupt the pathway of Barrett’s esophagus progression to cancer?
In patients with Barrett’s esophagus (BE), anti-reflux surgery aims to sustainable control reflux symptoms and heal reflux induced esophageal mucosal inflammation and prevent progression of BE to adenocarcinoma. There is growing evidence that beside gastric acid, bile salts in refluxed duodenal juic...
Salvato in:
| Pubblicato in: | Transl Gastroenterol Hepatol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327172/ https://ncbi.nlm.nih.gov/pubmed/30701208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.11.07 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|